This article was reviewed by Wallace Chamon, MD
This article was reviewed by Fengju Zhang, MD
The number of people affected by diabetes is expected to exceed 640 million by 2040.
Segment 2. Joseph Panarelli, MD, reviews the available topical treatment landscape for the management of open-angle glaucoma.
Key opinion leaders review approaches used to improve outcomes in patients with open-angle glaucoma.
Segment 1. Sahar Bedrood, MD, PhD, provides an overview on the role of IOP in open-angle glaucoma and parameters that contribute to IOP.
Impairment or total absence of corneal sensation are the hallmarks of neurotrophic keratopathy, an uncommon degenerative disease.
Quality-of-life issues have stepped into the spotlight for glaucoma, and ophthalmologists are learning how to incorporate new insights and tools into their clinical practice.
The silent nature of glaucoma makes the disease especially challenging, which is why Prevent Blindness is collaborating with other leading eye care groups in declaring January as National Gl